Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Invacare (NYSE: IVC ) , a global manufacturer and supplier of medical equipment for the health care and home health industries, jumped as much as 17% after reporting market-topping third-quarter earnings results.
So what: For the quarter, net sales decreased 5.6% from the year-ago period to $341.2 million, primarily as a result of a 7% decline in organic net sales. European sales proved to be a strong point for Invacare while the remainder of its global operations struggled -- especially its North American home health segment. However, the company's adjusted net loss came in at $0.18 per share, which was $0.08 smaller than Wall Street had predicted. In addition, Invacare nearly doubled the amount of free cash flow generated during the quarter to $29.4 million from the $15.6 million reported at this time last year.
Now what: Keep in mind that the revenue year-over-year comparisons aren't completely clean since it divested Invacare Supply Group earlier this year, but its 5.6% decline in organic year-over-year sales isn't very encouraging despite what the earnings beat might imply. True, the company did reduce its inventory, which is a good sign for pricing power down the road, but the cooling off of North American markets to its products is a bit of a worrisome sign. I certainly wouldn't want to count on Europe to continue to bail out my bottom line given how austerity measures throughout that group of countries can wreak havoc with spending patterns in all industries. With Invacare essentially hugging the flat-line of profitability when it comes to fiscal 2014 expectations, I would rather wait on the sidelines until I see a marked improvement in its other core markets.
Growth isn't a problem for this high-flying stock
The health care industry certainly affords investors ample opportunities for growth, but this incredible tech stock is growing twice as fast as Google and Facebook, and more than three times as fast as Amazon.com and Apple. Watch our jaw-dropping investor alert video today to find out why The Motley Fool's chief technology officer is putting $117,238 of his own money on the table, and why he's so confident this will be a huge winner in 2013 and beyond. Just click here to watch!